Impact of detergents on the activity of acetylcholinesterase and on the effectiveness of its inhibitors

Biological Chemistry

Volumn 390, Issue 1, 2009, Pages 19-26

  Zimmermann, Martina ^a,b   Westwell, Martin S ^a   Greenfield, Susan A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Acetylcholinesterase; Activity enhancement; Cholesterol; Detergent; Inhibition

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; DETERGENT; PROCAINE; TETRABUTYLAMMONIUM;

ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; HYDROLYSIS; KINETICS; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ANIMALS; CHOLINESTERASE INHIBITORS; DETERGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORUS; KINETICS; OCTOXYNOL; SOLVENTS;

EID: 58249099965     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.005     Document Type: Article

References (53)

1. al Jafari, A.A., Kamal, M.A., Duhaiman, A.S., and Alhomida, A.S. (1996). Kinetics of the inhibition of acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom by local anesthetics: procaine and tetracaine. J. Enzyme Inhib. 11, 123-134.
2. Arendt, T., Bruckner, M.K., Lange, M., and Bigl, V. (1992). Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - a study of molecular forms. Neurochem. Int. 21, 381-396.
3. Bartus, R.T., Dean, R.L. III, Beer, B., and Lippa, A.S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
4. Boeck, A.T., Schopfer, L.M., and Lockridge, O. (2002). DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase. Biochem. Pharmacol. 63, 2101-2110.
5. Bon, S. and Massoulie, J. (1980). Collagen-tailed and hydrophobic components of acetylcholinesterase in Torpedo marmorata electric organ. Proc. Natl. Acad. Sci. USA 77, 4464-4468.
6. Borroni, B., Pettenati, C., Bordonali, T., Akkawi, N., Di Luca, M., and Padovani, A. (2003). Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease. Neurosci. Lett. 343, 213-215.
7. Bourne, Y., Taylor, P., Bougis, P.E., and Marchot, P. (1999). Crystal structure of mouse acetylcholinesterase - a peripheral site-occluding loop in a tetrameric assembly. J. Biol. Chem. 274, 2963-2970.
8. Burns, M. and Duff, K. (2002). Cholesterol in Alzheimer's disease and tauopathy. Ann. NY Acad. Sci. 977, 367-375.
9. Chahinian, H., Nini, L., Boitard, E., Dubes, J.P., Comeau, L.C., and Sarda, L. (2002). Distinction between esterases and lipases: a kinetic study with vinyl esters and TAG. Lipids 37, 653-662.
10. Cheetham, P.S. (1979). Removal of triton X-100 from aqueous solution using amberlite XAD-2. Anal. Biochem. 92, 447-452.
11. Colletier, J.P., Fournier, D., Greenblatt, H.M., Stojan, J., Sussman, J.L., Zaccai, G., Silman, I., and Weik, M. (2006). Structural insights into substrate traffic and inhibition in acetylcholinesterase. EMBO J. 25, 2746-2756.
12. Cygler, M., Schrag, J.D., Sussman, J.L., Harel, M., Silman, I., Gentry, M.K., and Doctor, B.P. (1993). Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins. Protein Sci. 2, 366-382.
13. Dutta-Choudhury, T.A. and Rosenberry, T.L. (1984). Human erythrocyte acetylcholinesterase is an amphipathic protein whose short membrane-binding domain is removed by papain digestion. J. Biol. Chem. 259, 5653-5660.
14. Ellman, G.L., Courtney, K.D., Andres, V. Jr., and Feather-Stone, R.M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
15. Eryurek, F.G., Surmen, E., Oner, P., Altug, T., and Oz, H. (1990). Gamma-glutamyl transpeptidase and acetylcholinesterase activities in brain capillaries of cholesterol-fed rabbits. Res. Commun. Chem. Pathol. Pharmacol. 69, 245-248.
16. Greenblatt, H.M., Kryger, G., Lewis, T., Silman, I., and Sussman, J.L. (1999). Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 Å resolution. FEBS Lett. 463, 321-326.
17. Greenfield, S. (1984). Acetylcholinesterase may have novel functions in the brain. Trends Neurosci. 7, 364-368.
18. Greenfield, S.A. (1991). A noncholinergic action of acetylcholin-esterase (AChE) in the brain: from neuronal secretion to the generation of movement. Cell. Mol. Neurobiol. 11, 55-77.
19. Greenfield, S.A., Zimmermann, M., and Bond, C.E. (2008). Non-hydrolytic functions of acetylcholinesterase. The significance of C-terminal peptides. FEBS J. 275, 604-611.
20. Hayden, K.M., Zandi, P.P., Lyketsos, C.G., Khachaturian, A.S., Bastian, L.A., Charoonruk, G., Tschanz, J.T., Norton, M.C., Pieper, C.F., Munger, R.G., et al. (2006). Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis. Assoc. Disord. 20, 93-100.
21. Holloway, P.W. (1973). A simple procedure for removal of Triton X-100 from protein samples. Anal. Biochem. 53, 304-308.
22. Horikawa, S. and Ogawara, H. (1979). A simple and rapid procedure for removal of Triton X-100 from protein solution. Anal. Biochem. 97, 116-119.
23. Inestrosa, N.C., Dinamarca, M.C., and Alvarez, A. (2008). Amyloid-cholinesterase interactions. Implications for Alzheimer's disease. FEBS J. 275, 625-632.
24. Jiang, H. and Zhang, X.J. (2008). Acetylcholinesterase and apoptosis. A novel perspective for an old enzyme. FEBS J. 275, 612-617.
25. Kalman, J., Juhasz, A., Janka, Z., Rakonczay, Z., Abraham, G., Boda, K., Farkas, T., and Penke, B. (2004a). Serum butyrylcholinesterase activity in hyperlipidaemia. Atherosclerosis 173, 145-146.
26. Kalman, J., Juhasz, A., Rakonczay, Z., Abraham, G., Zana, M., Boda, K., Farkas, T., Penke, B., and Janka, Z. (2004b). Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients. Life Sci. 75, 1195-1204.
27. Krupka, R.M. and Hellenbrand, K. (1974). Specific versus non-specific interactions of mammalian and insect acetylcholinesterase with substrates and reversible inhibitors. Biochim. Biophys. Acta 370, 208-215.
28. Li, B., Stribley, J.A., Ticu, A., Xie, W., Schopfer, L.M., Hammond, P., Brimijoin, S., Hinrichs, S.H., and Lockridge, O. (2000). Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 75, 1320-1331.
29. Liu, Y.Q., Xin, T.R., Lu, X.Y., Ji, Q., Jin, Y., and Yang, H.D. (2007). Memory performance of hypercholesterolemic mice in response to treatment with soy isoflavones. Neurosci. Res. 57, 544-549.
30. Marquis, J.K. (1983). Properties of acetylcholinesterase in lobster axonal membrane. Comp. Biochem. Physiol. C 74, 119-124.
31. Massoulie, J., Pezzementi, L., Bon, S., Krejci, E., and Vallette, F.M. (1993a). Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 41, 31-91.
32. Massoulie, J., Sussman, J., Bon, S., and Silman, I. (1993b). Structure and functions of acetylcholinesterase and butyrylcholinesterase. Prog. Brain Res. 98, 139-146.
33. Paraoanu, L.E. and Layer, P.G. (2008). Acetylcholinesterase in cell adhesion, neurite growth and network formation. FEBS J. 275, 618-624.
34. Perez-Guillermo, F., Garcia-Carmona, F., Garcia-Canovas, F., and Vidal, C.J. (1987). Influence of NaCl on the kinetic behaviour of mammalian muscle acetylcholinesterase. Biochem. Int. 14, 385-394.
35. Poirier, J., Delisle, M.C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Bertrand, P., Nalbantoglu, J., Gilfix, B.M., and Gauthier, S. (1995). Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 12260-12264.
36. Rosenberry, T.L. and Scoggin, D.M. (1984). Structure of human erythrocyte acetylcholinesterase. Characterization of intersubunit disulfide bonding and detergent interaction. J. Biol. Chem. 259, 5643-5652.
37. Rosenfeld, C., Kousba, A., and Sultatos, L.G. (2001). Interactions of rat brain acetylcholinesterase with the detergent Triton X-100 and the organophosphate paraoxon. Toxicol. Sci. 63, 208-213.
38. Shin, S., Roth, L.G., and Chen, C.H. (1991a). Ethanol- acetylcholinesterase-inhibitor interactions: inhibitor hydrophobicity and site specificity dependence. Int. J. Biochem. 23, 1131-1136.
39. Shin, S., Wu, P., and Chen, C.H. (1991b). Biochemical studies of the actions of ethanol on acetylcholinesterase activity: ethanol-enzyme-solvent interaction. Int. J. Biochem. 23, 169-174.
40. Silman, I., Harel, M., Axelsen, P., Raves, M., and Sussman, J.L. (1994). Three-dimensional structures of acetylcholinesterase and of its complexes with anticholinesterase agents. Biochem. Soc. Trans. 22, 745-749.
41. Sjogren, M. and Blennow, K. (2005). The link between cholesterol and Alzheimer's disease. World J. Biol. Psychiatry 6, 85-97.
42. Soreq, H. (2008). Introduction: cholinesterases, from molecular complexity to non-hydrolytic functions. FEBS J. 275, 603.
43. Soreq, H. and Seidman, S. (2001). Acetylcholinesterase - new roles for an old actor. Nat. Rev. Neurosci. 2, 294-302.
44. Spinedi, A., Pacini, L., and Luly, P. (1989). A study of the mechanism by which some amphiphilic drugs affect human erythrocyte acetylcholinesterase activity. Biochem. J. 261, 569-573.
45. Tara, S., Elcock, A.H., Kirchhoff, P.D., Briggs, J.M., Radic, Z., Taylor, P., and McCammon, J.A. (1998). Rapid binding of a cationic active site inhibitor to wild type and mutant mouse acetylcholinesterase: Brownian dynamics simulation including diffusion in the active site gorge. Biopolymers 46, 465-474.
46. Taylor, P. and Lappi, S. (1975). Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. Biochemistry 14, 1989-1997.
47. Taylor, P. and Radic, Z. (1994). The cholinesterases: from genes to proteins. Annu. Rev. Pharmacol. Toxicol. 34, 281-320.
48. Toiber, D. and Soreq, H. (2005). Cellular stress reactions as putative cholinergic links in Alzheimer's disease. Neurochem. Res. 30, 909-919.
49. Trescec, A., Simic, M., Branovic, K., Gebauer, B., and Benko, B. (1999). Removal of detergent and solvent from solvent-detergent-treated immunoglobulins. J. Chromatogr. A 852, 87-91.
50. Tsukamoto, I., Yokono, S., Komatsu, H., and Ogli, K. (1998). Effects of halothane and supporting membrane lipids on the activity of acetylcholinesterase. Toxicol. Lett. 100-101, 447-450.
51. White, B.J. and Harmon, H.J. (2002). Interaction of monosulfonate tetraphenyl porphyrin, a competitive inhibitor, with acetylcholinesterase. Biosens. Bioelectron. 17, 463-469.
52. Xie, W. and Du, L. (2005). High-cholesterol diets impair short-term retention of memory in alloxan-induced diabetic mice, but not acquisition of memory nor retention of memory in prediabetic mice. Life Sci. 77, 481-495.
53. Zimmermann, M., Grosgen, S., Westwell, M.S., and Greenfield, S.A. (2008). Selective enhancement of the activity of C-terminally truncated, but not intact, acetylcholinesterase. J. Neurochem. 104, 221-232.